PATENT CLAIM ANALYSIS

Application Number: 15886379
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "206000"]

Abstract:
A method for treating dementia with Lewy bodies (DLB) comprises administrating ceftriaxone to a subject in need thereof to treat the DLB syndromes such as cognitive decline and neurological deficit in the subject in need thereof. Ceftriaxone can be parenterally or orally administrated to the subject in a dosage of 1.5-35 mg/kg/day.

Claim (Index 4):
The method for treating DLB as claimed in  claim 3 , wherein ceftriaxone is administrated to the subject in a dosage of 1.62-16.2 mg/kg/day.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13801480', '13782160', '15079709', '14336634', '14820649']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7390661815951752
- 35 USC 102 Novelty (BERT): 0.4898620534275543
- Combined Prediction Score: 0.7141457687784132
- Mean Citation Score: 156.72861200000003
- Max Citation Score: 201.93219
- Similarity Product: 145.91839971028625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test